Trial Profile
Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- 20 Mar 2018 Status changed from recruiting to completed.
- 27 Dec 2016 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.
- 27 Dec 2016 Status changed from not yet recruiting to recruiting.